Diagnostic cardiac catheterization test;Diagnostische herzkatheteruntersuchung

Clinical Research in Cardiology

Volumn 97, Issue 8, 2008, Pages 475-512

  Hamm, Christian W ^a   Albrecht, Alexander ^b   Bonzel, Tassilo ^b   Kelm, Malte ^b   Lange, Helmut ^b   Schächinger, Volker ^b   Terres, Wolfram ^b   Voelker, Wolfram ^b  

^a KERCKHOFF HEART CENTER   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; GLITAZONE DERIVATIVE; HEPARIN; INSULIN; IOBITRIDOL; IODIXANOL; IOHEXOL; IOMEPROL; IOPAMIDOL; IOPROMIDE; IOVERSOL; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; METFORMIN;

ANAMNESIS; ANGIOCARDIOGRAPHY; CARDIOLOGY; COMORBIDITY; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART MUSCLE BIOPSY; HEMODYNAMICS; IMMUNE DEFICIENCY; INFECTION; PROPHYLAXIS; QUALITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT INDICATION;

CARDIOVASCULAR DISEASES; GERMANY; HEART CATHETERIZATION; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 51149114000     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-008-0686-1     Document Type: Review

References (98)

1. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ (2003) Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 348:491-499
2. Assmann G, Cullen P, Schulte H (2002) Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation 105:310-315
3. Auch-Schwelk W (1998) Koronarer Spasmus - ein klinisch relevantes Problem? Herz 23:106-115
4. Austen WG, Edwards JE, Frye RL et al (1975) A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 51, Suppl 4:5-40
5. Baker CS, Wragg A, Kumar S, De Palma R, Baker LR, Knight CJ (2003) A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol 41:2114-2118
6. Barrett BJ, Parfrey PS (2006) Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 354:379-386
7. Bashore TM, Bates ER, Berger PB et al (2001) American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 37:2170-2214
8. Bassand JP, Hamm CW, Ardissino D et al (2007) Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology. Eur Heart J 28:1598-1660
9. Beller GA, Bonow RO, Fuster V (2002) ACC revised recommendations for training in adult cardiovascular medicine. Core Cardiology Training II (COCATS 2) (revision of the 1995 COCATS training statement). J Am Coll Cardiol 39:1242-1246
10. Birck R, Krzossok S, Markowetz F, Schnulle P, van der Woude FJ, Braun C (2003) Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 362:598-603
11. Bonow RO, Carabello BA, Chatterjee K et al (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 48:e1-148
12. Bonzel T, Erbel R, Hamm CW et al (2007) Leitlinie Interventionelle Koronartherapie. Clin Res Cardiol im Druck
13. Briguori C, Colombo A, Airoldi F et al (2004) N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity. J Am Coll Cardiol 44:762-765
14. Brosius FC 3rd, Hostetter TH, Kelepouris E et al (2006) Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation. Circulation 114:1083-1087
15. Bruckenberger E (2006) 18. Herzbericht 2005 mit Transplantationschirurgie, Hannover [online: http://www.herzbericht.de/], abgerufen 20. 6. 2007
16. Bundesärztekammer (1990) Empfehlungen zur Patientenaufklärung. Dtsch Ärzteblatt 87:C-807-C809 [online: http://www.aekwl.de/fileadmin/ rechtsabteilung/doc/baek_patientenaufkl_190490.pdf]
17. Bundesärztekammer (1999) Bekanntmachung: Voraussetzungen gemäß § 135 Abs. 2 SGB V zur Ausführung und Abrechnung invasiv kardiologischer Leistungen (Vereinbarung zur invasiven Kardiologie). Dtsch Ärztebl 96:A2386-2388 [online: http://www.aerzteblatt.de/v4/archiv/ artikel.asp?src=suche&id=19092]
18. Bundesamt für Strahlenschutz (2003) Bekanntmachung der diagnostischen Referenzwerte für radiologische und nuklearmedizinische Untersuchungen vom 10. Juli 2003. Bundesanzeiger 143:17503
19. Bundesgeschäftsstelle Qualitätssicherung gGmbH (2004) BQS Qualitätsreport 2003. [online: http://www.bqsqualitaetsreport.de/Webs/bqs/ qualrep/2003/ergebnisse/] abgerufen 2. 12. 2005
20. Burwash IG, Thomas DD, Sadahiro M et al (1994) Dependence of Gorlin formula and continuity equation valve areas on transvalvular volume flow rate in valvular aortic stenosis. Circulation 89:827-835
21. Camici PG (2000) Positron emission tomography and myocardial imaging. Heart 83:475-480
22. Campeau L (1976) Letter: Grading of angina pectoris. Circulation 54:522-523
23. Chaitman BR, Bourassa MG, Davis K et al (1981) Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS). Circulation 64:360-367
24. Chambers J (2006) Low "gradient", low flow aortic stenosis. Heart 92:554-558
25. Cheitlin MD, Armstrong WF, Aurigemma GP et al (2003) ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation 108:1146-1162
26. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41
27. Cohn PF, Fox KM, Daly C (2003) Silent myocardial ischemia. Circulation 108:1263-1277
28. Cox CD, Tsikouris JP (2004) Preventing contrast nephropathy: what is the best strategy? A review of the literature. J Clin Pharmacol 44:327-337
29. De Backer G, Ambrosioni E, Borch-Johnsen K et al (2003) European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 24:1601-1610
30. Deutsche Krankenhausgesellschaft. Patientenrechte in Deutschland (Broschüre), 28. 3. 2003 [online: http://www.dkgev.de/dkgev.php/cat/116/ aid/238/title/Patientenrechte+in+Deutschland+%28Brosch%FCre%29] abgerufen 2. 12. 2005
31. Dietz R, Rauch B (2003) Leitlinie zur Diagnose und Behandlung der chronischen koronaren Herzerkrankung der Deutschen Gesellschaft für Kardiologie - Herz- und Kreislaufforschung (DGK). Z Kardiol 92:501-521
32. Driscoll D, Allen HD, Atkins DL et al (1994) Guidelines for evaluation and management of common congenital cardiac problems in infants, children, and adolescents. A statement for healthcare professionals from the Committee on Congenital Cardiac Defects of the Council on Cardiovascular Disease in the Young. American Heart Association. Circulation 90:2180-2188
33. Eagle KA, Berger PB, Calkins H et al (2002) ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 105:1257-1267
34. Eagle KA, Guyton RA, Davidoff R et al (2004) ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 110:e340-e437
35. Erbel R, Alfonso F, Boileau C et al (2001) Diagnosis and management of aortic dissection. Eur Heart J 22:1642-1681
36. Erhardt L, Herlitz J, Bossaert L et al (2002) Task force on the management of chest pain. Eur Heart J 23:1153-1176
37. Espinola-Klein C, Rupprecht HJ, Erbel R, Nafe B, Brennecke R, Meyer J (1998) Impact of restenosis 10 years after coronary angioplasty. Eur Heart J 19:1047-1053
38. European Society of Cardiology (2006) Deutsche Version EuroHeart Score [online: http://www.escardio.org/knowledge/decision_tools/heartscore/de/] abgerufen 2. 5. 2006
39. Fleisher LA, Eagle KA (2001) Clinical practice. Lowering cardiac risk in noncardiac surgery. N Engl J Med 345:1677-1682
40. Fox JM, Bjornsen KD, Mahoney LT, Fagan TE, Skorton DJ (2003) Congenital heart disease in adults: catheterization laboratory considerations. Catheter Cardiovasc Interv 58:219-231
41. Fox K, Garcia MA, Ardissino D et al (2006) Guidelines on the management of stable angina pectoris: executive summary. The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 27:1341-1381
42. Gibbons RJ, Balady GJ, Bricker JT et al (2002) ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 106:1883-1892
43. Gibbons RJ, Abrams J, Chatterjee K et al (2003) ACC/AHA 2002 guideline update for the management of patients with chronic stable angina - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 107:149-158
44. Gibson CM, Cannon CP, Daley WL et al (1996) TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93: 879-888
45. Gibson CM, Cannon CP, Murphy SA, et al (2000) Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 101:125-130
46. Gibson CM, Cannon CP, Murphy SA Marble SJ, Barron HV, Braunwald E (2002) Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation 105:1909-1913
47. Glagov S, Weisenberg E, Zarins CK, Stankunavicius T, Kolettis GJ (1987) Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316:1371-1375
48. Goldman L, Hashimoto B, Cook EF, Loscalzo A (1981) Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation 64:1227-1234
49. Gould KL, Kirkeeide RL, Buchi M (1990) Coronary flow reserve as a physiologic measure of stenosis severity. J Am Coll Cardiol 15:459-474
50. Grayburn PA, Eichhorn EJ (2002) Dobutamine challenge for low-gradient aortic stenosis. Circulation 106:763-765
51. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V (1999) Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 100:1481-1492
52. Hamm CW, Bösenberg H, Brennecke R et al (2001) Leitlinien zur Einrichtung und zum Betreiben von Herzkatheterräumen (1. Neufassung). Z Kardiol 90:367-376
53. Hamm CW (2004) Leitlinien: Akutes Koronarsyndrom, Teil 1: ACS ohne persistierende ST-Hebung. Z Kardiol 93:72-90
54. Hamm CW (2004) Leitlinien: Akutes Koronarsyndrom, Teil 2: Akutes Koronarsyndrom mit ST-Hebung. Z Kardiol 93:324-341
55. Hart D, Hillier MC, Wall BF (2002) Doses to patients from medical x-ray examinations in the UK - 2000 Review. National Radiology Protection Board NRPB-W14 [online: http://www.hpa.org.uk/radiation/publications/w_series_reports/ 2002/nrpb_w14.pdf]
56. Hirshfeld JW Jr, Balter S, Brinker JA et al (2005) ACCF/AHA/HRS/SCAI clinical competence statement on physician knowledge to optimize patient safety and image quality in fluoroscopically guided invasive cardiovascular procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. Circulation 111:511-532
57. Hufnagel G, Pankuweit S, Richter A, Schönian U, Maisch B (2000) The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results. Herz 25:279-285
58. Jo SH, Youn TJ, Koo BK et al (2006) Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. J Am Coll Cardiol 48:924-930
59. Kay J, Chow WH, Chan TM et al (2003) Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA 289:553-558
60. Kelm M, Schäfer S, Preik M, Schoebel FC, Preik-Steinhoff H, Strauer BE (1997) Koronare Vasomotion bei der koronaren Herzerkrankung - Bedeutung epikardialer und mikrozirkulatorischer Gefäße für die Myokardperfusion. Z Kardiol 86, Suppl 1:33-41
61. Kern MJ (2000) Coronary physiology revisited: practical insights from the cardiac catheterization laboratory. Circulation 101:1344-1351
62. Kern MJ, Meier B (2001) Evaluation of the culprit plaque and the physiological significance of coronary atherosclerotic narrowings. Circulation 103:3142-3149
63. Kuon E, Schmitt M, Dahm JB (2002) Significant reduction of radiation exposure to operator and staff during cardiac interventions by analysis of radiation leakage and improved lead shielding. Am J Cardiol 89:44-49
64. Kuon E, Glaser C, Dahm JB (2003) Effective techniques for reduction of radiation dosage to patients undergoing invasive cardiac procedures. Br J Radiol 76:406-413
65. Kuon E, Dahm JB, Empen K, Robinson DM, Reuter G, Wucherer M (2004) Identification of less-irradiating tube angulations in invasive cardiology. J Am Coll Cardiol 44:1420-1428
66. Langes K, Nienaber CA, Meinertz T (1997) Angina pectoris bei normalen Koronararterien (Mikrovascular-Angina/Syndrom X). Dtsch Med Wochenschr 122:33-38
67. Levenson B, Albrecht A, Göhring S et al (2003) 4. Bericht des Bundesverbandes Niedergelassener Kardiologen zur Qualitätssicherung in der diagnostischen und therapeutischen Invasivkardiologie 1999-2002. Herz 28:335-347
68. Mahrholdt H, Goedecke C, Wagner A et al (2004) Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 109:1250-1258
69. Möckel M, Bahr F, Leuner C, Kuhn H, Dietz R (2002) Empfehlungen zur Prophylaxe der durch Röntgen-Kontrastmittel (RKM) induzierten Nephropathie. Z Kardiol 91:719-726
70. Monin JL, Quere JP, Monchi M et al (2003) Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 108:319-324
71. Mühlberger V, Barbier V, Pachinger O (2004) Koronarangiographie und PCI in Österreich im Jahr 2003. J Kardiol 11:403-412
72. Naghavi M, Libby P, Falk E et al (2003) From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 108:1664-1672
73. Naghavi M, Libby P, Falk E et al (2003) From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 108:1772-1778
74. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R (1999) European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16:9-13
75. Nishimura RA, Grantham JA, Connolly HM, Schaff HV, Higano ST, Holmes DR Jr (2002) Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory. Circulation 106: 809-813
76. Nixdorff U (2002) Dobutamin wurde für die Indikation Stressechokardiographie zugelassen (Stellungnahme der Kommission für Klinische Kardiologie über die Anwendung von Dobutamin zur Stressechokardiographie). [online: http://www.dgk.org/Aktuelles/DSE-Zulassung. pdf] abgerufen 2. 12. 2005
77. O'Rourke RA, Brundage BH, Froelicher VF et al (2000) American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation 102:126-140
78. Parzeller M, Wenk M, Zedler B, Rothschild M (2007) Aufklärung und Einwilligung bei ärztlichen Eingriffen. Dtsch Ärzteblatt 104:A576-584 [online: http://www.aerzteblatt.de/v4/archiv/pdf.asp?id=54690]
79. Samyn MM (2004) A review of the complementary information available with cardiac magnetic resonance imaging and multi-slice computed tomography (CT) during the study of congenital heart disease. Int J Cardiovasc Imaging 20:569-578
80. Scanlon PJ, Faxon DP, Audet AM et al (1999) ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 33:1756-1824
81. Scanlon PJ, Faxon DP, Audet AM et al (1999) ACC/AHA guidelines for coronary angiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions. Circulation 99:2345-2357
82. Schächinger V, Zeiher AM (2001) Prognostic implications of endothelial dysfunction: does it mean anything? Coron Artery Dis 12:435-443
83. Schühlen H, Kastrati A, Mehilli J, Hausleiter J, Pache J, Dirschinger J, Schomig A (2004) Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement. Am Heart J 147:317-322
84. Silber S, Albertsson P, Aviles FF et al (2005) Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26:804-847
85. Silber S, Hoffmeister HM, Drexler C, Schächinger V, Kuon E (2005) Arbeitsanweisung im HKL gem. § 18 Abs. (2) Röntgenverordnung für eine Röntgeneinrichtung zur Anwendung von Röntgenstrahlung am Menschen als Muster. Clin Res Cardiol 95, Suppl 4:72-75 [online: http://leitlinien.dgk. org/images/pdf/leitlinien_volltext/2005-07_arbeitsanweisung_hkl.pdf]
86. Somerville J (1997) Management of adults with congenital heart disease: an increasing problem. Annu Rev Med 48:283-293
87. Stone GW, McCullough PA, Tumlin JA et al (2003) Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA 290:2284-2291
88. Sutton AG, Finn P, Grech ED, Hall JA, Stewart MJ, Davies A, de Belder MA (2001) Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization. Am Heart J 141:677-683
89. Takeda S, Rimington H, Chambers J (1999) The relation between transaortic pressure difference and flow during dobutamine stress echocardiography in patients with aortic stenosis. Heart 82:11-14
90. The study group Clinical Issues, working group Coronary Circulation, of the European Society of Cardiology (1996) Recommendations for training and quality control in coronary angioplasty. Eur Heart J 17:1477-1481
91. TIMI study group (1985) The Thrombolysis in Myocardial Infarction (TIMI) trial: phase 1 findings. N Engl J Med 312:932-936
92. Trappe HJ, Löllgen H (2000) Leitlinien zur Ergometrie. Z Kardiol 89:821-831
93. Vahanian A, Baumgartner H, Bax J et al (2007) Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 28:230-268
94. van Buuren F, Horstkotte D (2006) 21. Herzbericht über die Leistungszahlen der Herzkatheterlabore in der Bundesrepublik Deutschland. Clin Res Cardiol 95:383-387
95. Van de Werf F, Ardissino D, Betriu A et al (2003) Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 24:28-66
96. Werner W, Sperschneider H, Schubert J (2003) Leitlinien der Deutschen Gesellschaft für Urologie: Nierentransplantation (AWMF online), 15. 1. 2003 [online: http://www.uniduesseldorf.de/AWMF/ll-na/043-023.htm] abgerufen 2. 12. 2005
97. Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IF (1988) Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 60:299-308
98. Zimmermann R, vom Dahl J, Schafers M, Schwaiger M (2002) Positionsbericht nuklearkardiologische Diagnostik - Update. Z Kardiol 91: 88-92